Cargando…

Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled study

BACKGROUND: Risk factors for cytomegalovirus (CMV) disease in renal transplant recipients have been evaluated in industrialized countries with relatively low CMV seroprevalence. OBJECTIVES: We aimed to determine which factors are related to this illness in a high CMV seroprevalence country. PATIENTS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro-Rodríguez, Viviana, Herrera-Munoz, Alvaro, Castro, Adrián, Ramos-Esquivel, Allan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Diabetic Nephropathy Prevention 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607989/ https://www.ncbi.nlm.nih.gov/pubmed/28975107 http://dx.doi.org/10.15171/jnp.2017.39

Ejemplares similares

Importance of the cytomegalovirus seropositive recipient as a contributor to disease burden after solid organ transplantation
por: Emery, Vincent C., et al.
Publicado: (2012)

Holoendemic cytomegalovirus infection in renal transplant recipients.
por: Fiala, M., et al.
Publicado: (1976)

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients
por: Kim, Jong Man, et al.
Publicado: (2015)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2017)

Mucormycosis and Cytomegalovirus Co-infection in Renal Transplant Recipients
por: Gupta, K. L.
Publicado: (2017)

Cytomegalovirus infection in transplant recipients
por: Azevedo*, Luiz Sergio, et al.
Publicado: (2015)

2079. The Relation Between Panel Reactive Antibody Assay and Cytomegalovirus Reactivation in Seropositive Solid Organ Transplantation Recipients
por: Kwon, Da Eun, et al.
Publicado: (2018)

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation
por: Ljungman, Per, et al.
Publicado: (2020)

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
por: Restelli, Umberto, et al.
Publicado: (2019)

Transition from antigenemia to quantitative nucleic acid amplification testing in cytomegalovirus-seropositive kidney transplant recipients receiving preemptive therapy for cytomegalovirus infection
por: Nakamura, Mônica Rika, et al.
Publicado: (2022)

Cytomegalovirus Viremia in Renal Transplant Recipients After Influenza Vaccination
por: Khatri, Akshay M, et al.
Publicado: (2020)

Cytomegalovirus-Induced Adrenal Insufficiency in a Renal Transplant Recipient
por: Ardalan, M., et al.
Publicado: (2009)

Cytomegalovirus Reactivation in Adult Recipients of Autologous Stem Cell Transplantation: a Single Center Experience
por: Al-Rawi, Omar, et al.
Publicado: (2015)

Opportunistic infections (non-cytomegalovirus) in live related renal transplant recipients
por: Vinod, P. B., et al.
Publicado: (2009)

Cytomegalovirus Induced Interstitial Nephritis and Ureteral Stenosis in Renal Transplant Recipient
por: Bae, Sung Ha, et al.
Publicado: (2012)

Cytomegalovirus esophagitis presents as chest pain in a renal transplant recipient
por: Joo, Young Bin, et al.
Publicado: (2013)

An unusual pulmonary complication of cytomegalovirus infection in a renal transplant recipient
por: Jacques, Jeremy, et al.
Publicado: (2008)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Maertens, Johan, et al.
Publicado: (2017)

Incidence of Cytomegalovirus disease and viral replication kinetics in seropositive liver transplant recipients managed under preemptive therapy in a tertiary-care center in Mexico City: a retrospective cohort study
por: Fernández-García, Oscar A., et al.
Publicado: (2022)

Cytomegalovirus Infection and Unusual Early Graft Dysfunction in a Renal Transplant Recipient
por: Sanavi, Suzan, et al.
Publicado: (2009)

Human cytomegalovirus glycoprotein N polymorphisms among renal transplant recipients in India
por: Patro, A Raj Kumar, et al.
Publicado: (2014)

Invasive gastric mucormycosis and cytomegalovirus infection in an ABO incompatible renal transplant recipient
por: Nandwani, A., et al.
Publicado: (2015)

Postsurgical skin ulcers caused by cytomegalovirus vasculopathy in a renal transplant recipient
por: Rao, Shikha, et al.
Publicado: (2020)

Parathyroid hormone in renal transplanted recipients; a single center study
por: Nasri, Hamid, et al.
Publicado: (2013)

576. Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients
por: shi, yiyun, et al.
Publicado: (2020)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

Cutaneous involvement by cytomegalovirus in a renal transplant recipient as an indicator of severe systemic infection
por: Neumann, Antonielle Borges Faria, et al.
Publicado: (2016)

Infection in Renal Transplant Recipients
por: Kotton, Camille Nelson, et al.
Publicado: (2010)

Infection in Renal Transplant Recipients
por: Fishman, Jay A., et al.
Publicado: (2005)

Seropositivity of cytomegalovirus in patients with recurrent pregnancy loss
por: Sherkat, Roya, et al.
Publicado: (2014)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience
por: Abu Jawdeh, Bassam G., et al.
Publicado: (2017)

Human Cytomegalovirus (HCMV)-Specific CD4(+) and CD8(+) T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients
por: Gabanti, Elisa, et al.
Publicado: (2014)

1569. Incidence, Risk Factors, and Impact of Antiviral Prophylaxis Duration on Cytomegalovirus (CMV) Disease in High-Risk Donor Seropositive/Recipient Seronegative [D+R−] Orthotopic Heart Transplant Recipients (OHTR)
por: Carcoana, Allison Dumitriu, et al.
Publicado: (2018)

Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients
por: Egli, Adrian, et al.
Publicado: (2008)

Cytomegalovirus –The Quest for an Effective Vaccine in Transplant Recipients Continues
por: Boeckh, Michael, et al.
Publicado: (2015)

Viral Pneumonias Other Than Cytomegalovirus in Transplant Recipients
por: Barton, Todd D., et al.
Publicado: (2005)

Cytomegalovirus-Specific T Cells in Pediatric Liver Transplant Recipients
por: Getsuwan, Songpon, et al.
Publicado: (2023)

Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients
por: Zhu, Yuanjia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6n8j61v773a0pkadnaplfigdsh